Heron Therapeutics, Inc. (HRTX)
0.9152
0.00 (0.00%)
USD |
NASDAQ |
May 14, 16:00
0.9306
+0.02
(+1.68%)
After-Hours: 17:11
Heron Therapeutics EPS Diluted (Quarterly) : -0.0428 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.2446 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.111M |
| Revenue (Quarterly) | 34.71M |
| Total Expenses (Quarterly) | 42.82M |
| Enterprise Value | 270.98M |
| Gross Profit Margin (Quarterly) | 69.35% |
| Profit Margin (Quarterly) | -23.37% |
| Earnings Yield | -19.31% |
| Normalized Earnings Yield | -13.98 |